UTHR January 2026 Options Begin Trading

Analysis of United Therapeutics Corp (UTHR) options reveals potential strategies for investors. Selling a $280 put offers a cost basis of $247.40 with a 62% chance of expiring worthless, yielding a potential 19.40% annualized return. A covered call strategy involving selling a $300 call against purchased shares yields a potential 16.78% return if the stock is called away, with a 45% chance of the contract expiring worthless, translating to a 20.75% annualized yield boost; the implied volatility for puts and calls are 49% and 48% respectively, while the actual trailing twelve month volatility is 36%.

Analysis

The article details two options strategies for United Therapeutics Corp (UTHR), which is currently trading at $287.56 per share. For investors interested in acquiring UTHR, selling the $280.00 strike put contract, which has a current bid of $32.60, offers a potential cost basis of $247.40 if the shares are assigned. This put option has a 62% statistical probability of expiring worthless, in which case the collected premium would represent an 11.64% return on the cash commitment, or a 19.40% annualized YieldBoost. For current UTHR shareholders, a covered call strategy involves selling the $300.00 strike call contract, with a current bid of $35.80, against shares purchased at $287.56. This strategy could yield a total return of 16.78% if the stock is called away by the January 2026 expiration. There is a 45% chance this call option expires worthless, allowing the investor to keep the shares and the premium, which would represent a 12.45% additional return, or a 20.75% annualized YieldBoost. Notably, the implied volatility for the analyzed put (49%) and call (48%) options is significantly higher than UTHR's actual trailing twelve-month volatility of 36%, suggesting that options are currently pricing in greater future price fluctuations than observed historically, or that option premiums are relatively rich.

Key Decisions for Investors

• Investors considering initiating a position in UTHR could evaluate selling the $280 put to potentially acquire shares at a discounted cost basis of $247.40 or to generate a 19.40% annualized income if the option expires worthless.
• Current UTHR shareholders might explore the $300 covered call strategy for the January 2026 expiration to enhance income, potentially achieving a 20.75% annualized yield from the premium if the option expires unexercised, while acknowledging this caps upside gains beyond the $300 strike price.
• The disparity between high implied volatilities (48-49%) and lower historical volatility (36%) suggests option selling strategies could be attractive due to elevated premiums, but also signals market anticipation of increased price volatility for UTHR which should be factored into risk assessments.